Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 138 Schemes (43.71%)
Foreign Institutions
Held by 356 Foreign Institutions (18.8%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
3,538 Million
(Quarterly Results - Mar 2026)
Net Profit:
278 Million
Pharmaceuticals & Biotechnology
USD 21,770 Million (Mid Cap)
22.00
NA
0.00%
0.61
-999,999.00%
2.53






